The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The p53 tumour-suppressor protein controls the expression of a gene encoding the p21 cyclin-dependent protein kinase (CDK) regulator. Levels of p21 protein are increased in senescent cells and p21 overexpression blocks the growth of tumour cells. In normal human cells, but not in many tumour cells, p21 exists in a quaternary complex with a cyclin, a CDK, and the proliferating-cell nuclear antigen (PCNA). p21 controls CDK activity, thereby affecting cell-cycle control, whereas PCNA functions in both DNA replication and repair. Here we use simian virus 40 DNA replication in vitro to show than p21 directly inhibits PCNA-dependent DNA replication in the absence of a cyclin/CDK. Furthermore, p21 blocks the ability of PCNA to activate DNA polymerase delta, the principal replicative DNA polymerase. This regulation results from a direct interaction between p21 and PCNA. Thus, during p53-mediated suppression of cell proliferation, p21 and PCNA may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p21 was reported to block replicative DNA synthesis in vitro as well, doing so when reaching a 100:1 ratio [42,43,44].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [44]
In the citing paper
“suggesting that p21–PCNA interaction prevented rather than promoted cell-cycle arrest, as originally postulated based on its ability to displace replicative DNA polymerases from PCNA [43,44].”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [44]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Self-citationp21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Self-citationKastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
Wild-type p53 is a cell cycle checkpoint determinant following irradiation.
Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., & Kastan, M. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7491 · Cited by 1,837
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
Xiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021
Self-citationProliferating cell nuclear antigen is required for DNA excision repair
Shivji, M. K. K., Kenny, M. K., & Wood, R. D. (1992) · Cell · doi:10.1016/0092-8674(92)90416-a · Cited by 798
Cited by
Items 801–900 of 1,000
Yao, N., Hurwitz, J., & O'Donnell, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1421 · Cited by 39
Immunohistochemical study of p53, p21 and PCNA in pterygium
Ueda, Y., Kanazawa, S., Kitaoka, T., Dake, Y., Ohira, A., Ouertani, A. M., & Tsugio, T. (2001) · Acta Histochemica · doi:10.1078/0065-1281-00584 · Cited by 38
Restoration of Mutant TP53 to Normal TP53 Function by Glycerol as a Chemical Chaperone
Ohnishi, T., Ohnishi, K., Wang, X., Takahashi, A., & Okaichi, K. (1999) · Radiation Research · doi:10.2307/3579838 · Cited by 42
Stewart, M. C., Kadlcek, R. M., Robbins, P. D., MacLeod, J. N., & Ballock, R. T. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0301209 · Cited by 43
Proliferating Cell Nuclear Antigen Mutations Affect DNA Polymerase δ Processivity
Arroyo, M. P., Downey, K. M., So, A. G., & Wang, T. S. ‐. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.15971 · Cited by 44
Future prospects in prostate cancer
Hegarty, N. J., Fitzpatrick, J. M., Richie, J. P., Scardino, P. T., White, R. D., Schr�der, F. H., & Coffey, D. S. (1999) · The Prostate · doi:10.1002/(sici)1097-0045(19990901)40:4<225::aid-pros3>3.0.co;2-3 · Cited by 45
Shi, Y., Zou, M., Farid, N., & Al‐Sedairy, S. T. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.546 · Cited by 44
Livneh, Z. (2006) · Cell Cycle · doi:10.4161/cc.5.17.3193 · Cited by 38
Masuo, T., Okamura, S., Zhang, Y., & Mori, M. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.05.001 · Cited by 38
Scorah, J., Dong, M., Yates, J. R., Scott, M. T., Gillespie, D. A., & McGowan, C. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800369200 · Cited by 42
Zhang, C., Wang, J., Lü, G., Li, J., Lu, X., Mantion, G., Vuitton, D. A., Wen, H., & Lin, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030127 · Cited by 44
DNA Replication: A familiar ring to DNA polymerase processivity
Wyman, C., & Botchan, M. R. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00065-0 · Cited by 38
Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development
Watanabe, G., Pena, P., Shambaugh, G. E., Haines, G. K., & Pestell, R. G. (1998) · Developmental Brain Research · doi:10.1016/s0165-3806(98)00032-7 · Cited by 40
Inhibiting CDK inhibitors: new lessons from DNA tumor viruses
Funk, J. O., & Galloway, D. A. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01242-0 · Cited by 38
Mahran, Y. F., El‐Demerdash, E., Nada, A. S., Ali, A. A., & Abdel‐Naim, A. B. (2013) · Endocrinology · doi:10.1210/en.2013-1214 · Cited by 37
Wei, L., Lin, J., Wu, G., Xu, W., Li, H., Hong, Z., & Peng, J. (2013) · Oncology Reports · doi:10.3892/or.2013.2250 · Cited by 37
Control of mouse hepatocyte proliferation and ploidy by p53 and p53ser246 mutation in vivo
Yin, L., Ghebranious, N., Chakraborty, S., Sheehan, C. E., Ilic, Z., & Sell, S. (1998) · Hepatology · doi:10.1002/hep.510270113 · Cited by 38
Inhibition of cell proliferation by the PCNA-binding region of p21 expressed as a GFP miniprotein.
Mattock, H., Lane, D., & Warbrick, E. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5160 · Cited by 38
p21 response to DNA damage induced by genistein and etoposide in human lung cancer cells
Ding, H., Duan, W., Zhu, W., Ju, R., Srinivasan, K., Otterson, G. A., & Villalona-Calero, M. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00873-8 · Cited by 37
Xie, D., Lan, L., Huang, K., Chen, L., Xu, C., Wang, R., Shi, Y., Wu, X., Wang, L., Liu, Y., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3538 · Cited by 37
Tan, M., Wang, S., Song, J., & Jia, J. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.03.093 · Cited by 38
Small-Scale Density Gradient Sedimentation to Separate and Analyze Multiprotein Complexes
Tanese, N. (1997) · Methods · doi:10.1006/meth.1997.0475 · Cited by 37
Ou, Y. C., Thompson, S. A., Ponce, R. A., Schroeder, J. L., Kavanagh, T. J., & Faustman, E. M. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8685 · Cited by 37
Expression of p21CIP1/WAF1 in Chondrocytes
Stewart, M. C., Farnum, C. E., & MacLeod, J. N. (1997) · Calcified Tissue International · doi:10.1007/s002239900323 · Cited by 41
Camplejohn, R., Perry, P., Hodgson, S. V., Turner, G. S., Williams, A. C., Upton, C., MacGeoch, C., Mohammed, S. N., & Barnes, D. M. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.390 · Cited by 37
Kallassy, M., Martel, N., Damour, O., Yamasaki, H., & Nakazawa, H. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199801)21:1<26::aid-mc5>3.3.co;2-p · Cited by 37
Huang, Y., Yoon, M.-K., Otieno, S., Lelli, M., & Kriwacki, R. W. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.11.011 · Cited by 36
Bouffard, S., Dambroise, E., Brombin, A., Lempereur, S., Hatin, I., Simion, M., Corre, R., Bourrat, F., Joly, J., & Jamen, F. (2018) · Developmental Biology · doi:10.1016/j.ydbio.2018.02.006 · Cited by 38
AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy
Yan, B., Claxton, D. F., Huang, S., & Qiu, Y. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.06.003 · Cited by 38
Li, M., Deng, Y., Zhuo, M., Zhou, H., Kong, X., Xia, X., Su, Z., Chen, Q., Guo, P., Mo, P., et al. (2020) · Theranostics · doi:10.7150/thno.45581 · Cited by 39
Shiraishi, K., Naito, K., & Yoshida, K. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)65831-4 · Cited by 36
Cotto-Rios, X. M., Jones, M. V., & Huang, T. T. (2011) · Cell Cycle · doi:10.4161/cc.10.23.18501 · Cited by 38
Murakami, K., Mitomi, H., Yamashita, K., Tanabe, S., Saigenji, K., & Okayasu, I. (2001) · American Journal of Clinical Pathology · doi:10.1309/vlf5-ucnh-xqm2-x410 · Cited by 38
Regulation of replication fork speed: Mechanisms and impact on genomic stability
Merchut‐Maya, J. M., Bártek, J., & Maya‐Mendoza, A. (2019) · DNA repair · doi:10.1016/j.dnarep.2019.102654 · Cited by 37
Nakazawa, K., Sahuc, F., Damour, O., COLLOMBEL, C., & Nakazawa, H. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00204.x · Cited by 45
A Positive Role for the Ku Complex in DNA Replication Following Strand Break Damage in Mammals
Park, S.-J., Ciccone, S. L. M., Freie, B. W., Kurimasa, A., Chen, D. J., Li, G. C., Clapp, D. W., & Lee, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311054200 · Cited by 40
Deeds, L., Teodorescu, S., Chu, M., Yu, Q., & Chen, C.-Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306854200 · Cited by 36
Labrie, C., Lee, B. H., & Mathews, M. B. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.18.3732 · Cited by 40
Haapajärvi, T., Pitkänen, K., Tsubari, M., & Laiho, M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.6.3074 · Cited by 35
Inhibition of p53-Mediated Growth Arrest by Overexpression of Cyclin-Dependent Kinases
Latham, K. M., Eastman, S. W., Wong, A., & Hinds, P. W. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4445 · Cited by 36
Li, D., Guang-ren, L., Zhang, B., FENG, J.-J., & Zhao, H. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2430 · Cited by 36
Yan, B., Chen, Q., Xu, J., Li, W., Xu, B., & Qiu, Y. (2020) · Leukemia · doi:10.1038/s41375-020-0710-7 · Cited by 35
Prognostic Significance of p21WAF1/CIP1 Expression in Tongue Squamous Cell Carcinomas
Xie, X., Clausen, O. P. F., & Boysen, M. (2002) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.128.8.897 · Cited by 35
Shimura, T., Toyoshima, M., Adiga, S. K., Kunoh, T., Nagai, H., Shimizu, N., Inoue, M., & Niwa, O. (2006) · Oncogene · doi:10.1038/sj.onc.1209624 · Cited by 35
Role of cell‐cycle regulators in lung cancer
Caputi, M., Russo, G. M., Esposito, V., Mancini, A., & Giordano, A. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20424 · Cited by 40
Kalra, N., Arora, A., & Shukla, Y. (2006) · PubMed · Cited by 35
Ser326Cys polymorphism inhOGG1 gene and risk of esophageal cancer in a Chinese population
Xing, D.-Y., Tan, W., Song, N., & Lin, D. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010520)95:3<140::aid-ijc1024>3.0.co;2-2 · Cited by 161
Han, J. H., Roh, M. S., Park, C., Park, K. C., Cho, K. H., Kim, K. H., Eun, H. C., & Chung, J. H. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.02.002 · Cited by 35
Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression
Ono, Y., Tamiya, T., Ichikawa, T., Matsumoto, K., Furuta, T., Ohmoto, T., Akiyama, K., Seki, S., Ueki, K., & Louis, D. N. (1997) · Acta Neuropathologica · doi:10.1007/s004010050667 · Cited by 35
p21WAF1/CIP1 Expression in breast cancers: associations with p53 and outcome
Thor, A. D., Liu, S., Moore, D. H., Shi, Q., & Edgerton, S. M. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006455526894 · Cited by 35
Wenz, F. K., Azzam, E. I., & Little, J. B. (1998) · Radiation Research · doi:10.2307/3579679 · Cited by 37
Maheshwari, M., Yadav, N., Hasanain, M., Pandey, P. K., Sahai, R., Choyal, K., Singh, A., Nengroo, M. A., Saini, K. K., Kumar, D., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05486-1 · Cited by 40
Birner, P., Schoppmann, A., Schindl, M., Dinhof, C., Jesch, B., Berghoff, A. S., & SCHOPPMANN, S. F. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200463 · Cited by 36
Roy, S., Das, R., Ghosh, B., & Chakraborty, T. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22792 · Cited by 35
Functions of Multiple Clamp and Clamp-Loader Complexes in Eukaryotic DNA Replication
Ohashi, E., & Tsurimoto, T. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6955-0_7 · Cited by 36
Lin, S., Yang, X., Long, Y., Zhong, H., Wang, P., Yuan, P., Zhang, X., Che, L., Feng, B., Li, J., et al. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520001774 · Cited by 39
Function of p21 and its therapeutic effects in esophageal cancer (Review)
Wang, L., Han, H., Dong, L., Wang, Z., & Qin, Y. (2020) · Oncology Letters · doi:10.3892/ol.2020.12397 · Cited by 38
The cell cycle: A critical therapeutic target to prevent vascular proliferative disease
Charron, T., Nili, N., & Strauss, B. H. (2006) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(06)70986-2 · Cited by 41
Kim, S. S., Shetty, K., Katuri, V., Kitisin, K., Baek, H. J., Tang, Y., Marshall, B., Johnson, L. B., Mishra, B., & Mishra, L. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.236 · Cited by 40
Wang, Z., Sturgis, E. M., Zhang, F., Lei, D., Liu, Z., Xu, L., Song, X., Wei, Q., & Li, G. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-17 · Cited by 36
Yoon, M., Venkatachalam, V., Huang, A., Choi, B., Stultz, C. M., & Chou, J. J. (2009) · Protein Science · doi:10.1002/pro.34 · Cited by 44
Kao, J., Chuah, S., Huang, C., Chen, C., Wang, C., Hung, C., Chen, C., Wang, J., Lu, S., Lee, C., et al. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01499.x · Cited by 34
Sarbia, M., Stahl, M., Hausen, A. Z., Zimmermann, K., Wang, L., Fink, U., Heep, H., Dutkowski, P., Willers, R., Müller, W., et al. (1998) · PubMed · Cited by 38
The Prognostic Value of P53 in Superficially Infiltrating Transitional Cell Carcinoma
Vatne, V., Maartmann-Moe, H., & Hostmark, J. G. (1995) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365599509180032 · Cited by 34
The Cdk and PCNA domains on p21Cip1both function to inhibit G1/S progression during hyperoxia
Helt, C. E., Staversky, R. J., Lee, Y., Bambara, R. A., Keng, P. C., & O’Reilly, M. A. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00243.2003 · Cited by 45
Ha-rasVal12Oncogene Increases Susceptibility of NIH/3T3 Cells to Lovastatin
Chang, M.-Y., Jan, M., Won, S., & Liu, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8911 · Cited by 33
Yasd, W., Akama, Y., Yokozaki, H., Semba, S., Kudo, Y., Shimamoto, F., & 田原, 榮. (1997) · Pathology International · doi:10.1111/j.1440-1827.1997.tb04526.x · Cited by 36
The Human T-Cell Lymphoma/Leukemia Viruses: SPECIAL ARTICLE
Poiesz, B. J., Poiesz, M. J., & Choi, D. (2003) · Cancer Investigation · doi:10.1081/cnv-120016422 · Cited by 42
Up-Regulation of p21WAF1/CIP1 in Psoriasis and After the Application of Irritants and Tape Stripping
Healy, E., Reynolds, N. J., Smith, M. D., Harrison, D. J., Doherty, E., Campbell, C., & Rees, J. L. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12318430 · Cited by 33
Ruscetti, F. W., Birchenall-Roberts, M. C., McPherson, J. M., & Wiltrout, R. H. (1998) · Elsevier eBooks · doi:10.1016/b978-012498340-3/50029-4 · Cited by 35
Sarbishegi, M., Khani, M., Salimi, S., Valizadeh, M., & Aval, F. S. (2015) · Nephro-Urology Monthly · doi:10.5812/numonthly.33180 · Cited by 33
Hematopoietic-Specific Deletion of Foxo1 Promotes NK Cell Specification and Proliferation
Huang, P., Wang, F., Yang, Y., Lai, W., Meng, M., Wu, S., Peng, H., Wang, L., Zhan, R., İmani, S., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01016 · Cited by 40
Smith, S. J., Li, C. M., Lingeman, R. G., Hickey, R. J., Liu, Y., Malkas, L. H., & Raoof, M. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.03.025 · Cited by 33
Lee, M., Zhang, S., Lin, S. H. S., Wang, X., Darżynkiewicz, Z., Zhang, Z., & Lee, E. (2013) · Cell Cycle · doi:10.4161/cc.27407 · Cited by 37
A PCNA-Derived Cell Permeable Peptide Selectively Inhibits Neuroblastoma Cell Growth
Gu, L., Smith, S. J., Li, C., Hickey, R. J., Stark, J. M., Fields, G. B., Lang, W. H., Sandoval, J. A., & Malkas, L. H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094773 · Cited by 34
Keratinocyte Growth Factor Increases Hair Follicle Survival Following Cytotoxic Insult
Booth, C. E., & Potten, C. S. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00927.x · Cited by 36
Zenmyo, M., Komiya, S., Hamada, T., Hiraoka, K., Kato, S., Fujii, T., Yano, H., Irie, K., & Nagata, K. (2001) · Human Pathology · doi:10.1053/hupa.2001.23524 · Cited by 34
Bocchia, M., Xu, Q. L., Wesley, U. V., Xu, Y., Korontsvit, T., Loganzo, F., Albino, A. P., & Scheinberg, D. A. (1997) · Leukemia Research · doi:10.1016/s0145-2126(96)00085-9 · Cited by 33
Tannoch, V. J., Hinds, P. W., & Tsai, L. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46817-4_12 · Cited by 40
Cell Cycle Control in Fission Yeast and Mammals: Identification of New Regulatory Mechanisms
Okayama, H., Nagata, A., Jinno, S., Murakami, H., Tanaka, K., & Nakashima, N. (1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60859-3 · Cited by 34
Heikinheimo, O., Hsiu, J.-G., Gordon, K., Kim, S., Williams, R. F., Gibbons, W. E., & Hodgen, G. D. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00113-6 · Cited by 33
Bistable switches as integrators and actuators during cell cycle progression
Stallaert, W., Kedziora, K. M., Chao, H. X., & Purvis, J. E. (2019) · FEBS Letters · doi:10.1002/1873-3468.13628 · Cited by 36
Golubnitschaja, O., Moenkemann, H., Kim, K., & Mozaffari, M. S. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00285-5 · Cited by 34
Interaction between proliferating cell nuclear antigen (PCNA) and a DnaJ induced by DNA damage
Yamamoto, T., Mori, Y., Ishibashi, T., Uchiyama, Y., Ueda, T., Ando, T., Hashimoto, J., Kimura, S., & Sakaguchi, K. (2005) · Journal of Plant Research · doi:10.1007/s10265-005-0197-3 · Cited by 33
Cell cycle regulation and its aberrations in human lung carcinoma
Dobashi, Y. (2005) · Pathology International · doi:10.1111/j.1440-1827.2005.01799.x · Cited by 32
Apoptosis and Cell Cycle-related Genes and Proteins in Classical Hodgkin Lymphoma
Wang, J., & Taylor, C. R. (2003) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200309000-00002 · Cited by 32
van Gijssel, H. E., Ohlson, L. C., Torndal, U.-B., Mulder, G. J., Eriksson, L. C., Porsch-Hällström, I., & Meerman, J. H. (2000) · Hepatology · doi:10.1053/jhep.2000.17660 · Cited by 35
Tumor Suppressor Genes and Human Cancer
Brown, M. A. (1997) · Advances in genetics · doi:10.1016/s0065-2660(08)60307-7 · Cited by 39
Absence of a Mutation of the p21/WAF1 Gene in Human Lung and Pancreatic Cancers
Shimizu, T., Miwa, W., Nakamori, S., Ishikawa, O., Konishi, Y., & Sekiya, T. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb00217.x · Cited by 32
Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation
el-Mahdani, N., Vaillant, J. C., Guiguet, M., Prevot, S., Bertrand, V., Bernard, C., Parc, R., Bereziat, G., & Hermelin, B. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.92 · Cited by 36
Izban, K. F., Alkan, S., Singleton, T. P., & Hsi, E. D. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-1457-miaotc · Cited by 32
Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis
Cho, J.-H., & Kim, W. H. (1998) · Pathology - Research and Practice · doi:10.1016/s0344-0338(98)80054-x · Cited by 32
Ribault, D., Habib, M., Khatib, A., Barbara, A., & Mitrovic, D. R. (1998) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(97)00115-2 · Cited by 33
Follis, A. V., Galea, C. A., & Kriwacki, R. W. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0659-4_3 · Cited by 32
Zhang, S., Li, Y., Li, L., Zhang, Y., Gao, N., Zhang, Z., & Zhao, H. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2008.06.079 · Cited by 31
López‐Marure, R., Ventura, J. L., Sánchez, L. S., Montaño, L. F., & Zentella‐Dehesa, A. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01436.x · Cited by 34
Levesque, M. A., Katsaros, D., Massobrio, M., Genta, F. T., Yu, H., Richiardi, G., Fracchioli, S., Durando, A., Arisio, R., & Diamandis, E. P. (2000) · PubMed · Cited by 30
Toki, T., Mori, A., Shimizu, M., Nikaido, T., & Fujii, S. (1998) · Molecular Human Reproduction · doi:10.1093/molehr/4.12.1157 · Cited by 35
Cerrato, J. A., Yung, W. K. A., & Liu, T.-J. (2001) · Neuro-Oncology · doi:10.1093/neuonc/3.2.113 · Cited by 31
Arita, Y., Buffolino, P., & Coppock, D. L. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3911 · Cited by 31
Metadata
- Authors
- Waga, S., Hannon, G. J., Beach, D., & Stillman, B.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1994-06
- Volume
- 369
- Issue
- 6481
- Pages
- 574-578
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2003282728
- Cited by
- 1,655
- References
- 31
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 21 · 2023: 22 · 2022: 25 · 2021: 17 · 2020: 25 · 2019: 31 · 2018: 23 · 2017: 25 · 2016: 23 · 2015: 25 · 2014: 27 · 2013: 23 · 2012: 49
- FWCI
- 55.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- p21, cyclin-dependent kinases, PCNA, proliferating cell nuclear antigen, DNA replication, DNA polymerase delta, p53, cell cycle regulation, DNA repair, protein-protein interaction, tumor suppression
- MeSH terms
- Cell Division, Cell Line, DNA Polymerase III, DNA-Directed DNA Polymerase, DNA Replication, DNA Topoisomerases, Type I, DNA, Viral, Histidine, Humans, Nuclear Proteins, Recombinant Proteins, Simian virus 40, Cyclins, Proliferating Cell Nuclear Antigen, Protein Kinase Inhibitors, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.